The trademark application CORRECTSEQ TX was filed by CorrectSequence Therapeutics Co., Ltd, a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 28, 2023, and it was registered by office on January 5, 2024 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and professional address of the trademark registration was recorded on November 13, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Biological preparations for medical purposes
Surgical implants comprised of living tissues
Stem cells for medical purposes
Biological tissue cultures for medical purposes
Immunostimulants
Pre-filled syringes for medical purposes
Human allogeneic tissues
Medical cell
Biochemicial drug
Blood products
Living cells for medical purposes
Reagents for medical purposes
Medical cell function activating drug
Medical cell inhibitor
Graft (living tissue)
Vaccine preparations
Diagnostic reagents for medical purposes
Diagnostic preparations for medical and veterinary use.
The mark was filed in class 42 with following description of goods:
Technological research
Technical project studies
Scientific research
Biological research
Clinical trials
Medical research
Culturing of cells for scientific research purposes
Scientific research in the field of genetics
Medical laboratory service
Genetic screening [for scientific purposes]
Biological cloning services
Biological research and analysis
Stem cell research services
Structural and functional analysis of genomes
Research and development of antibodies
Genetic testing for scientific research
Biotechnological research
Medical research service
Development of pharmaceutical preparations and pharmaceuticals
Biomedical research
DNA screening (for scientific research purposes)
Pharmaceutical research
Research services relating to medicines
Drug development
Vaccine research and development services
Cell culture services for scientific and research purposes for others
Genetic testing of laboratory animals for research purposes
Research in the field of DNA repair technology
Research in the field of genome editing.
The mark was filed in class 44 with following description of goods:
Therapy services
Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Medical treatment using cultured cells
Cultured cell bank services for medical transplantation
Stem cell therapy services
Genetic testing for medical purposes
DNA screening (for medical purposes)
Medical services relating to the removal, treatment and processing of human cells
Medical services relating to the removal, treatment and processing of human blood
Medical services relating to the removal, treatment and processing of stem cells